Can-Fite BioPharma Ltd. (CANF) Total liabilities 2018–2025
Can-Fite BioPharma Ltd. (CANF) total liabilities at each fiscal year-end, per SEC filings.
$3.9MFY2025 · since FY2018: $4.9M → $3.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.9M | +6.5% |
| FY2024 | $3.7M | -1.7% |
| FY2023 | $3.7M | -22.1% |
| FY2022 | $4.8M | -18.1% |
| FY2021 | $5.9M | +70.2% |
| FY2020 | $3.4M | -39.8% |
| FY2019 | $5.7M | +16.1% |
| FY2018 | $4.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CANF financial trends
CANF RevenueCANF Net incomeCANF Net marginCANF Gross profitCANF Gross marginCANF Operating incomeCANF Operating marginCANF Operating cash flowCANF Free cash flowCANF Capital expendituresCANF Return on equityCANF Stock buybacksCANF Dividends paidCANF Total assetsCANF Shareholders’ equityCANF overview →